A Multicenter Study of Long-Term Clinical Outcomes of Immune Globulin Subcutaneous (Human) (SCIG) IgPro20 in Subjects With Primary Immunodeficiency

Trial Profile

A Multicenter Study of Long-Term Clinical Outcomes of Immune Globulin Subcutaneous (Human) (SCIG) IgPro20 in Subjects With Primary Immunodeficiency

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Dec 2014

At a glance

  • Drugs Immune globulin (Primary)
  • Indications Common variable immunodeficiency
  • Focus Registrational; Therapeutic Use
  • Sponsors CSL Behring
  • Most Recent Events

    • 01 Dec 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 12 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top